Press release
Nigerian Scientist Shalom Emmanuel Earns Global Recognition for Drug Safety Breakthroughs
Image: https://www.abnewswire.com/upload/2025/11/067ae2372158a81f193363c674c298cf.jpgIn the high-stakes world of pharmaceutical research, where precision can save lives, Shalom Emmanuel is making waves. A Nigerian-born Ph.D. candidate at Texas Southern University, she's gaining international acclaim for her pioneering work in drug metabolism and pharmacokinetics (DMPK), the science of how medicines work in the body. Her journey from Nigeria to Texas exemplifies how global talent drives American innovation, delivering safer drugs to patients worldwide.
Emmanuel's research is both meticulous and transformative. Her 2025 paper in Metabolites, "Development and Validation of a Novel LC-MS/MS Method for Alvocidib Quantification," introduced a technique that enhances how scientists measure drug safety, vital for therapies reaching millions. Her 2024 study in Molecules, "Species Differences in Ezetimibe Glucuronidation," uncovered metabolic variations that could disrupt drug trials, earning citations in global pharmacology discussions. "Shalom's work is setting new industry standards," says Dr. Gao Song, her advisor at Texas Southern. "Her methods are reshaping how we design and test drugs."
These achievements aren't just academic. Published in Scopus-indexed journals like Metabolites, Molecules, and Analytical Methods, Emmanuel's studies are shaping pharmaceutical practices. Her work's global citations reflect its influence, positioning her among the top researchers in her field. "My goal is to make medicines safer by understanding exactly how they're metabolized," she says. "Each discovery moves us toward therapies that work for diverse populations."
Beyond the lab, Emmanuel holds the Certified Forensic Chemistry Project Auditor (CFCPA) credential from the American Academy of Project Management, a rare distinction earned by fewer than 5% of applicants globally. This certification underscores her expertise in forensic analytics, ensuring drug data is as reliable as the science behind it. "It's about accountability," she notes. "Safe medicines depend on trustworthy data."
Her leadership extends to mentoring and evaluation. In 2024, she served as a judge for Nigeria's Wella Well Health Business Competition, assessing innovative health solutions by medical students. This role, uncommon for a graduate researcher, highlights her growing reputation as an authority in scientific innovation. "The students' creativity was inspiring," she says. "It shows innovation thrives in Nigeria and beyond."
Emmanuel's accolades tell a story of relentless excellence: First Place at Georgia Southern University's 2021 Graduate Research Symposium, selected from hundreds of researchers; Helen Giddings Scholarships (2023-2024); a Dean's Scholarship; and a $160,000 Ph.D. assistantship. She's also a member of elite associations, American Association of Pharmaceutical Scientists (AAPS), American Society for Pharmacology and Experimental Therapeutics (ASPET), and American Association for the Advancement of Science (AAAS) each requiring outstanding achievements.
From Nigeria's Landmark University to Texas Southern's labs, Emmanuel bridges continents through science. Her collaborations with international teams ensure drugs meet stringent regulatory standards, impacting patients from Lagos to Los Angeles. "Science is universal," she says. "Discoveries start in local labs but save lives globally."
In a U.S. landscape hungry for STEM talent, Emmanuel's story underscores the value of global innovators. Her work doesn't just advance pharmaceuticals, it sets a benchmark for what dedication and precision can achieve. As she continues to redefine drug safety, her contributions remind us why the world's best minds choose America to make a difference.
Learn more about Emmanuel's work at Texas Southern University's College of Pharmacy (http://www.tsu.edu/pharmacy) (http://www.tsu.edu/pharmacy).
Media Contact
Company Name: TSU
Contact Person: SHALOM EMMANUEL
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=nigerian-scientist-shalom-emmanuel-earns-global-recognition-for-drug-safety-breakthroughs]
Phone: (912) 220-0651
City: Houston
State: Texas
Country: United States
Website: http://www.tsu.edu/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Nigerian Scientist Shalom Emmanuel Earns Global Recognition for Drug Safety Breakthroughs here
News-ID: 4260065 • Views: …
More Releases from ABNewswire
Ophthalmoscopes Market to Reach USD 294.90 Million by 2034, Growing at 5.24% CAG …
Leading ophthalmoscopes companies in the market include Baxter, HEINE Optotechnik GmbH & CO. KG, Keeler, US Ophthalmic, Rudolf Riester GmbH, Opticlar, Zumax Medical Co., Ltd., Girodmedical, Adam Rouilly Ltd., Timesco Healthcare Ltd., Zhejiang Honsun Medical Technology Co., Ltd., Iridex Corporation, NIDEK CO., Ltd., OSCAR BOSCAROL S.r.l, American Diagnostic Corporation, Lumenis Be Ltd., Veatch Ophthalmic Instruments, KIRCHNER &WILHELM GmbH + Co. KG, oDocs Eye care, Revenio Group, and others.
The global ophthalmoscopes…
RINVOQ Market Growth Accelerates Across IBD, Dermatology, and Rheumatology as Gl …
The global immunology market is witnessing a significant transformation as RINVOQ (upadacitinib) continues to demonstrate strong prescription growth, expanding indications, and robust revenue performance.
DelveInsight's "RINVOQ Sales Forecast, and Market Size Analysis - 2034" report provides comprehensive insights of RINVOQ for approved indications like Ankylosing Spondylitis, Atopic Dermatitis, Axial SpA, Crohn's Disease, Giant Cell Arteritis, Psoriatic Arthritis, Rheumatoid Arthritis, and Ulcerative Colitis; as well as potential indications like Alopecia Areata, Hidradenitis…
Prostate Cancer Competitive Landscape Analysis 2026: Clinical Trial Trends, Nove …
Leading Prostate Cancer companies include Merck & Co., Inc., Telix Pharmaceuticals Limited, Exelixis, Inc., AstraZeneca PLC, Pfizer Inc., Bristol-Myers Squibb Company, AbbVie Inc., BeiGene, Ltd., and Ipsen S.A., among many others-are actively developing next-generation therapies to reshape the treatment landscape.
The treatment paradigm for prostate cancer is witnessing rapid transformation, with more than 150 companies advancing innovative drug candidates across diverse clinical phases. Recent milestones include multiple FDA fast-track designations, companion…
Electrosurgical Devices Market to Reach USD 10,220.04 Million by 2034, Growing a …
Electrosurgical Devices Companies in the market include B. Braun Melsungen AG, ConMed Corporation, Olympus Corporation, Apyx Medical Corporation, Medtronic, Johnson & Johnson, Smith & Nephew Plc, Erbe Elektromedizin GmbH, KLS Martin Group, BOWA-electronic GmbH & Co. KG, Modern Medical, Kirwan Surgical Products, LLC, Utah Medical Products, Inc., Hangzhou AGS MedTech Co., Ltd., New Deantronics Taiwan Ltd., Parkell, Inc., Surgical Holdings, CIMPAX, Boston Scientific Corporation, and Others
The global electrosurgical devices market…
More Releases for Emmanuel
Dr. Emmanuel Eni Amadi: The Scientist Pioneering Nanotoxicology and Reshaping Me …
From the quiet lab benches of the University of Bradford in West Yorkshire, England, UK, to the most prestigious international stages of nanotechnology, a single scientist is creating a monumental wave of change. Dr. Emmanuel Eni Amadi, PhD, Executive MBA, MSc, PGDip, B.Pharm-a Nanotoxicologist, Medical Researcher, prolific Author, and a UK-based Clinical Pharmacist-is also the visionary CEO/Founder and a dynamic entrepreneur of Amadi Global Leadership Academy | Executive Education, who…
Marvin Emmanuel Launches Website Dedicated to Cultural Restoration, Faith-Driven …
New Platform Features Acclaimed Book 'Cry for Help' and Expands Mission to Empower Black America Through Storytelling, Strategy, and Social Change
ATLANTA, GA - June 9, 2025 - Author, speaker, and cultural strategist Marvin Emmanuel has officially launched a new digital platform, JamieFoxxLetter.com, a site dedicated to fostering racial dialogue, restoring African American community ties, and inspiring faith-led cultural change. More than a book site, the platform is a growing resource…
Readers' Favorite announces the review of the Fiction - Science Fiction book "Fi …
Image: https://www.globalnewslines.com/uploads/2025/03/1741174182.jpg
Readers' Favorite announces the review of the Fiction - Science Fiction book "First Elite" by Emmanuel M Arriaga, currently available at http://www.amazon.com/gp/product/B0DP7Z72BQ.
Readers' Favorite is one of the largest book review and award contest sites on the Internet. They have earned the respect of renowned publishers like Random House, Simon & Schuster, and Harper Collins, and have received the "Best Websites for Authors" and "Honoring Excellence" awards from the Association…
Emmanuel Iyere: An Innovator and a Leader in Fraud Detection and Prevention
Emmanuel Iyere, known for his technological innovations, blends leadership and expertise to shape the evolving landscape of business intelligence effectively.
Image: https://www.getnews.info/uploads/c5bd3bfaed6fee67e5af654cc622b278.jpg
Introduction
Emmanuel Iyere, a distinguished EPM and fraud prevention expert, has made significant strides in cybersecurity, business intelligence, and digital marketing. Awarded the 2024 Global Recognition Award, Iyere has demonstrated his commitment to combating financial fraud through innovative technological solutions and his dedication to advancing industry practices.
Innovations in Fraud Prevention
A highlight…
Discover the Profound Wisdom of the Bible with Emmanuel Piedad Mullaneda's "Easi …
Understanding the Bible's Teachings and Their Relevance to Your Life.
Los Angeles, CA - July 16, 2024 - Emmanuel Piedad Mullaneda is thrilled to announce the release of his enlightening new book, "Easiest Guide to Bible Study," now available on Amazon. This comprehensive guide is designed to help readers of all backgrounds and levels of familiarity with the Bible to understand its profound messages and teachings more easily.
"Easiest Guide to Bible…
Emmanuel Karolitsky Releases New Children's Book - The Adventures of Honey: The …
Join Honey on a tail-wagging adventure that will leave you eager for the next chapter in this charming series of dog detective tales!
Emmanuel Karolitsky, a talented 12-year-old author from Bradford, Ontario, Canada, announces the release of his debut children's book, The Adventures of Honey: The Bacon Betrayer. As the author and illustrator, Emmanuel hopes this thrilling tale marks the beginning of an exciting series of dog detective adventures.
In The Adventures…
